Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 4
1991 3
1992 3
1993 9
1994 2
1995 9
1996 9
1997 10
1998 10
1999 10
2000 10
2001 5
2002 5
2003 10
2004 22
2005 18
2006 18
2007 20
2008 18
2009 21
2010 26
2011 24
2012 21
2013 25
2014 38
2015 30
2016 27
2017 37
2018 29
2019 30
2020 43
2021 41
2022 37
2023 29
2024 28
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

599 results

Results by year

Filters applied: . Clear all
Page 1
Drug-Drug Interactions with Direct Oral Anticoagulants.
Foerster KI, Hermann S, Mikus G, Haefeli WE. Foerster KI, et al. Among authors: haefeli we. Clin Pharmacokinet. 2020 Aug;59(8):967-980. doi: 10.1007/s40262-020-00879-x. Clin Pharmacokinet. 2020. PMID: 32157630 Free PMC article. Review.
IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression.
Sadik A, Somarribas Patterson LF, Öztürk S, Mohapatra SR, Panitz V, Secker PF, Pfänder P, Loth S, Salem H, Prentzell MT, Berdel B, Iskar M, Faessler E, Reuter F, Kirst I, Kalter V, Foerster KI, Jäger E, Guevara CR, Sobeh M, Hielscher T, Poschet G, Reinhardt A, Hassel JC, Zapatka M, Hahn U, von Deimling A, Hopf C, Schlichting R, Escher BI, Burhenne J, Haefeli WE, Ishaque N, Böhme A, Schäuble S, Thedieck K, Trump S, Seiffert M, Opitz CA. Sadik A, et al. Among authors: haefeli we. Cell. 2020 Sep 3;182(5):1252-1270.e34. doi: 10.1016/j.cell.2020.07.038. Epub 2020 Aug 19. Cell. 2020. PMID: 32818467 Free article.
Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial.
Veltkamp R, Korompoki E, Harvey KH, Harvey ER, Fießler C, Malzahn U, Rücker V, Montaner J, Caso V, Sibon I, Ringleb P, Halse O, Hügen K, Ullmann S, Schuhmann C, Todd GP, Haas K, Palà E, Debette S, Lachaize M, D'Aoust T, Enzinger C, Ropele S, Fandler-Höfler S, Haidegger M, Wang Y, Wafa HA, Cancelloni V, Mosconi MG, Lip GYH, Lane DA, Haefeli WE, Foerster KI, Wurmbach VS, Nielsen PB, Hajjar K, Müller P, Poli S, Purrucker J, Laible M, D'Anna L, Silva Y, de Torres Chacon R, Martínez-Sánchez P, Boulanger M, Norrving B, Paré G, Wachter R, Ntaios G, Wolfe CDA, Heuschmann PU; PRESTIGE-AF Consortium. Veltkamp R, et al. Among authors: haefeli we. Lancet. 2025 Mar 15;405(10482):927-936. doi: 10.1016/S0140-6736(25)00333-2. Epub 2025 Feb 26. Lancet. 2025. PMID: 40023176 Free article. Clinical Trial.
[Good prescribing practice].
Seidling HM, Haefeli WE. Seidling HM, et al. Among authors: haefeli we. Ther Umsch. 2014 Jun;71(6):313-6. doi: 10.1024/0040-5930/a000518. Ther Umsch. 2014. PMID: 24867345 Review. German.
Medication safety through e-health technology: can we close the gaps?
Seidling HM, Kaltschmidt J, Ammenwerth E, Haefeli WE. Seidling HM, et al. Among authors: haefeli we. Br J Clin Pharmacol. 2013 Sep;76 Suppl 1(Suppl 1):i-iv. doi: 10.1111/bcp.12217. Br J Clin Pharmacol. 2013. PMID: 24007455 Free PMC article. No abstract available.
Oral Drugs Against COVID-19.
Mikus G, Foerster KI, Terstegen T, Vogt C, Said A, Schulz M, Haefeli WE. Mikus G, et al. Among authors: haefeli we. Dtsch Arztebl Int. 2022 Apr 15;119(15):263-269. doi: 10.3238/arztebl.m2022.0152. Dtsch Arztebl Int. 2022. PMID: 35302484 Free PMC article.
In Reply.
Haefeli WE. Haefeli WE. Dtsch Arztebl Int. 2022 Nov 4;119(44):761-762. doi: 10.3238/arztebl.m2022.0261. Dtsch Arztebl Int. 2022. PMID: 36655292 Free PMC article. No abstract available.
[Tablet splitting].
Quinzler R, Haefeli WE. Quinzler R, et al. Among authors: haefeli we. Ther Umsch. 2006 Jun;63(6):441-7. doi: 10.1024/0040-5930.63.6.441. Ther Umsch. 2006. PMID: 16841582 Review. German.
Acute antiarrhythmic effects of SGLT2 inhibitors-dapagliflozin lowers the excitability of atrial cardiomyocytes.
Paasche A, Wiedmann F, Kraft M, Seibertz F, Herlt V, Blochberger PL, Jávorszky N, Beck M, Weirauch L, Seeger T, Blank A, Haefeli WE, Arif R, Meyer AL, Warnecke G, Karck M, Voigt N, Frey N, Schmidt C. Paasche A, et al. Among authors: haefeli we. Basic Res Cardiol. 2024 Feb;119(1):93-112. doi: 10.1007/s00395-023-01022-0. Epub 2024 Jan 3. Basic Res Cardiol. 2024. PMID: 38170280 Free PMC article.
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial.
Wedemeyer H, Schöneweis K, Bogomolov P, Blank A, Voronkova N, Stepanova T, Sagalova O, Chulanov V, Osipenko M, Morozov V, Geyvandova N, Sleptsova S, Bakulin IG, Khaertynova I, Rusanova M, Pathil A, Merle U, Bremer B, Allweiss L, Lempp FA, Port K, Haag M, Schwab M, Zur Wiesch JS, Cornberg M, Haefeli WE, Dandri M, Alexandrov A, Urban S. Wedemeyer H, et al. Among authors: haefeli we. Lancet Infect Dis. 2023 Jan;23(1):117-129. doi: 10.1016/S1473-3099(22)00318-8. Epub 2022 Sep 13. Lancet Infect Dis. 2023. PMID: 36113537 Clinical Trial.
599 results